Go to Rhinology journal submission/review system to submit your article. If this is your first manuscript, you will need to create a user account. Before you prepare your manuscript, please download our template to ensure it is formatted correctly.

If you have already prepared your paper, please use 'copy - paste special - unformatted text' to enter your text in the template.

Please save your completed manuscript in the Word template in .doc(x) or .rtf format. Upload all figures and tables as separate files. Further instructions are available in the template.

For editors and reviewers to accurately assess the work presented in your manuscript you need to ensure the English language is of sufficient quality to be understood. If you need help with writing in English, you should consider asking a colleague who is a native English speaker to review your manuscript for clarity

Alternatively, we provide a language editing service where editors will improve the English to ensure that your meaning is clear and identify problems that require your review. We provide this service for 100 euro/1000 words. We will usually return your manuscript within one week.

The manuscript

Manuscripts should be complete in all respects. The manuscript should be typed in double spacing on one side only of A4 paper (21x27.9 cm) with ample (2.5 cm) top and left-hand margins. Figures and Tables should be referred to in consecutive order as 'Figure 1', etc. and 'Table 1', etc.

Original papers should be divided into sections: Summary, Key words, Introduction, Materials and Methods, Results, Discussion, Acknowledgements, References, Tables, Legends for illustrations, and Legends for tables. After the last reference, the title, name, and full postal address of the corresponding author should be typed. Begin each section and Figure and Table legends on a separate sheet, and type the page number in the upper right-hand corner of each page.

The front page of the manuscript should contain:

(1) title of the manuscript (not exceeding 100 characters including spaces);

(2) name of author(s);

(3) name of department(s), institution(s) and/or laboratories;

(4) full postal address of the author from whom reprints should be requested (please include telephone and/or telefax numbers and e-mail address);

(5) running title not exceeding 30 characters including space;

(6) five key words for indexing purposes using MeSH terms.


Reviews should present an update of the most recent developments in a particular field of rhinologic research. We encourage the submission of high-quality colour pictures and cartoons.


  • max 4,500 words not including abstract, figure legends and references (please supply a word count)
  • up to 100 references in the Journal's style (if more, justification should be provided)
  • figures and tables are important in review papers and up to 10 figures and/or tables (total) can be included in the text


  • should be concise and descriptive
  • less than 100 characters

The number of authors should be limited to five (if more, justification should be provided)

Short title of less than 50 characters

Abstract: 200 words unstructured summary

Key words: up to five, listed in alphabetical order

Review articles should be reported according to PRISMA guidelines.

Letters to the Editor

Letters to the Editor are brief reports that can be preliminary but may represent original observations that could have a substantial impact within the scope of Rhinology. They will be subject to peer review and will be indexed in Medline.

Rhinology will also accept Letters to the Editor that are comments on papers published in Rhinology. The commentaries are published at the Editor's discretion and should be submitted no later than six months after publication of the article they are commenting on. Commentaries on previously published articles should make specific reference to issues and causes related to it, and will only be published in cases where the Editor deems that significant scientific controversy exists. Letters are subject to abridgement and editing for style and content.

Letters which comment on a previously published article will in most cases be sent to the authors of the original article, who will be given the opportunity to reply, and the letter and reply may subsequently be published together

Please note that single case reports will not be considered for publication.


Should be concise and informative and less than 100 characters. Please also provide a short title of 50 characters.


  • max 600 words not including abstract, figure legends and references (please supply a word count)
  • up to nine references, one of which should be to the article commented on, if relevant
  • the article should begin with the salutation 'To the Editor'
  • there should be no separate abstract, or other divisions in the text, but rather a conclusion paragraph that sums up the Letter (a short conclusive summary, max 100 words)
  • author names, affiliations, funding sources and conflicts of interests should be listed at the end following references
  • Only one (1) display item (figure or table) is allowed. The legend should be concise and should not be more than 100 words.
  • Online supplementary can be used for more references, detailed explanations of methods, sequencing databases, tables and figures.

List of abbreviations

If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations should be provided at the end following references.

Original articles

We welcome high quality original publications dealing with innovative aspects of rhinologic research.


  • should be concise and informative
  • less than 100 characters

Short title of less than 50 characters

Abstract or summary: 250 words structured as follows:

  • background (including the aims of the study)
  • methods (if space is short, report only the primary outcomes)
  • results
  • conclusions

Key words: up to five, listed in alphabetical order


The text is limited to:

  • max 3,500 words not including abstract, figure legends and references (please supply a word count)
  • up to 50 references in the Journal's style
  • up to six figures and/or tables (total)

Please state in the cover letter any reasons for increase in length, number of figures or tables or number of references.

Note: Original articles are limited to five printed pages in total. Authors must pay GBP 80 for each additional page.

Clinical trials and randomized trials should be reported according to CONSORT guidelines. Clinical trials must be prospectively registered in a publicly accessible database, such as or Include the name of the trial register and your clinical trial registration number at the end of the article abstract.


Every paper should include a factual summary/abstract of its contents. It should be intelligible in itself, without reference to the paper, and not exceed 250 words. It must include statement of problem, method(s) of study, main results ( in words only, no statistics), and principal conclusions. Footnotes and references are not used in the summary.


Use commas to separate the different keywords. Use MeSH words as indicated in PubMed


Citations in the text should be referred to using the Vancouver system in which a number is assigned to each reference as it is used. This should appear in superscript inside the text punctuation. Even if the author(s) is named, a number must still be used.

  • The full reference must be listed in numerical order at the end of the paper in the bibliography.
  • The original number assigned to the reference is used each time the reference is cited in the text, regardless of its position in the text.

Journal titles should be abbreviated according to the style used in Index Medicus (Medline). A list of abbreviated names of frequently cited journals is printed annually in the January issue of Index Medicus. They can also be found listed at the US National Library of Medicine website at

Use the style of the examples below, which are based on the formats used by the National Library of Medicine. When you use Endnote or Reference Manager, remove all embedded links in the final document to prevent incompatibilities with editorial software

References should be formatted according to the following examples:

Extract from Adams JC, Hamblen DL. Outline of fractures. 10th ed. Edinburgh: Churchill Livingstone, 1992:

In younger patients operative repair is advised. It entails exposure of the tendon from above by splitting the acromion in the coronal plane, and reattachment of the tendon by sutures through drill holes in the tuberosity of the humerus (1,2). Thereafter a long course of supervised exercises may be required before a full range of active movement is restored. As would be expected, the results of operation tend to be poorer in cases of large musculo-teninous defects than when the rent is small (2).

  • Debeyre J, Patte D, Elmelik E. Repair of ruptures of the rotator cuff of the shoulder. J Bone Joint Surg Br. 1965; 47B: 36-42.
  • Kessel L, Bayley I. Clinical disorders of the shoulder. 2nd ed. Edinburgh: Churchill Livingstone, 1986.


  • An article in a journal: (List all authors when six or less; when seven or more, list only first three and add et al).You CH, Lee KY, Chey WY, Menguy R. Electrogastrographic study of patients with unexplained nausea, bloating and vomiting. Gastroenterology 1980; 79: 311-314.
  • A corporate author: The Royal Marsden Hospital Bone-Marrow Transplantation Team. Failure of syngeneic bone-marrow graft without preconditioning in post-hepatitis marrow aplasia. Lancet 1977; 2: 242-244.
  • No author given: Anonymous. Coffee drinking and cancer of the pancreas (Editorial). Br Med J 1981; 283: 628.

Books and other monographs

- Personal author(s):

Eisen HN. Immunology: an introduction to molecular and cellular principles of the immune response. 5th ed. New York: Harper and Row, 1974

- Editor, compiler, chairman as author:

Dausset J, Colombani J, eds. Histocompatibility testing 1972. Copenhagen: Munksgaard, 1973: 12-18.

- Chapter in a book:

Weinstein L, Swartz MN. Pathogenic properties of invading micro-organisms. In: Sodeman WA Jr, Sodeman WA, eds. Pathologic physiology: mechanisms of disease. Philadelphia: WB Saunders, 1974; 457-472.


Please submit high-resolution figures (300 dpi) that meet the following specifications:

File Sizes: Figure files should not exceed 10 MB (average size is about 2 MB).

Image Sizes: Figures should be submitted in final print publication size (printed 1:1). Figures may be published in print in one of two formats: single-column (8.5 cm) or double-column (18.0 cm). Unless the file size is too large, multi-panel figures should be submitted as a single file.

Text and Lines:Text in figures must be 6-8 points in size, except for single letter markers, which must be 12 points. Myriad Pro should be used for all figure text (except for the use of symbols). Line widths must be greater than one point thick or they will not appear on the PDF version of the article..

Numbering: Figures must be numbered as they appear in the text.

File Format: Original figures should be in TIFF (better for halftone art e.g., blots, photographs), or EPS (better for line art or monochrome art, i.e., anything that involves sharply delineated lines). Figures can be submitted in powerpoint with page setup at A4 size.

The editors will determine the degree of any reduction or enlargement required and, in general, line drawings will be reduced to one column width if possible. Authors may, however, request a larger reproduction. Specific requests should be typed on the relevant figure legend page. Photomicrographs will usually not be reduced unless the reduction involved is small or the height necessitates reduction.

Colour: Colour figures must be in the RGB colour space.

Permissions: It is the author’s responsibility to gain permission to reproduce any figures or tables in full or in part. Please provide evidence that permission has been granted where relevant.


Tables should be typed using the table function in Word or Pages, the required number of cells should be chosen, double spaced, and should contain only horizontal lines. Each table should be on a separate page, numbered consecutively with Arabic numerals 'Table 1', etc.

If a manuscript does not fulfil these requirements, it will be returned to the authors.

Supplementary materials

Rhinology accepts supplementary files to support the content of articles, such as videos, audio files, interactive maps, spreadsheets, and other types of supplemental content. The editorial office will work with authors on an individual basis to discuss submission of supplementary materials (file formats etc.). As a general rule, the maximum file size for supplementary files is 20 MB each, and files will be virus-scanned on submission. Each item of supplementary material should be cited in sequence within the main body of text.

Supplementary material should not include files such as patient consent forms, certificates of language editing, or revised versions of the main manuscript document with tracked changes. Such files, if requested, should be sent by email to the journal's editorial email address, quoting the manuscript reference number. Please do not send completed patient consent forms unless requested.

Results that would otherwise be indicated as "data not shown" should be included as supplementary material. Since many web links and URLs rapidly become broken, Rhinology requires that supporting data are included as supplementary material, or deposited in a recognized repository. Please do not link to data on a personal/departmental website. Do not include any individual participant details.

Case Reports

As from April 1, 2009, the journal does NOT accept Case Reports.


PDF proofs will be sent by e-mail to the first author of the paper, unless an alternative is requested on the title page of the manuscript. They should be checked carefully and returned by fax or e-mail within seven days to the Managing Editor. If the proofs are not received in time, the author is considered to accept the Editor's correction only. Corrections must be clearly indicated. The author is responsible for mistakes that have been overlooked. Changes or additions to the edited manuscripts, other than correcting printer's errors, are not allowed at this stage.


Reprints may be ordered by filling in and returning the order form sent with the PDF proof to the Managing Editor. One PDF file per contribution will be provided, free of charge.

Editorial policy

While papers are subject to peer review and editing, the journal does not hold itself responsible for all statements made by contributors.

The Editors reserve the right to refuse any manuscript submitted and to make suggestions for modifications before publication. Manuscripts are submitted to referees for peer review. The authors will receive confirmation of the arrival of their manuscripts. They will generally be notified of the editorial decision within two months. In case a manuscript is returned to the author for revision, it should be resubmitted through the website within six months. Papers accepted by the Editorial Board are scheduled for publication in chronological order of submission as much as possible. Every effort will be made to achieve rapid publication on our website as well as in print. This will be facilitated if authors provide good and complete copy by following these instructions.

The Editorial Board have a responsibility to prevent unethical practice and protect patients. As such, the Editors will carefully consider the moral justification for each article. They will assess factors such as potential burden and/or risks to patients; benefits to patients and society; to what extent the research conclusions deviate from accepted clinical practice. If there are any concerns regarding these points, we may request further explanation from the authors’, and in some cases from their institution and/or research ethics committee.

All submissions will be handled in confidence by editors and reviewers.


All sources of funding should be declared in a separate ‘Funding’ statement at the end of the article. Details of which aspects of the study received funding should also be declared, i.e. research design, execution, analysis, interpretation, reporting.

To comply with funding requirements, authors whose research has been funded by the National Institute of Health (USA) should upload their final, peer-reviewed manuscript to PubMed Central. Further details and instructions are available here: Submitting papers through the NIHMS: Methods C and D Best Practices |

Authorship and contributorship

Please describe the individual contributions of each author to your article. As per the ICMJE recommendations, to be listed as an author, you must have made significant contribution to the design and execution of the article, including:

  • acquisition, analysis, or interpretation of data
  • drafts and revisions during the writing process
  • final approval of the article before submission to Rhinology

As a listed author, you are also expected to be accountable for the accuracy and integrity of your part of the work undertaken.

Contributors who do not meet the above criteria should be credited in the Acknowledgements section.

Conflicts of interest / competing interests

Where an author’s private / other interests could be seen to have an impact on the objectivity and conclusions of their article this should be declared in a Conflict of Interest statement.

If no conflict of interest exists, the authors should also state this.

Ethics approval and consent to participate

Manuscripts reporting studies involving human participants, human data or human tissue must:

  • include a statement on ethics approval and consent (even where the need for approval was waived)
  • include the name of the ethics committee that approved the study and the committee’s reference number if appropriate
Studies involving animals must include a statement on ethics approval.

Consent for publication

If your manuscript contains any individual person’s data in any form (including individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent for publication.

You can use your institutional consent form or any other consent form that you prefer. The consent form should contain a signature of the patient/parent/ guardian/relative. You should not send the form to us on submission, but we may request to see a copy at any stage (including after publication).

Please keep this consent form in the patient’s case files. The manuscript reporting this patient’s details should state that ‘Written informed consent for publication of their clinical details and/or clinical images was obtained from the patient/parent/guardian/relative of the patient. A copy of the consent form is available for review by the Editor of this journal.

Data sharing and reproducibility

Rhinology strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files whenever possible.

Availability of data and materials

All manuscripts must include an ‘Availability of data and materials’ statement. Data availability statements should include information on where data supporting the results reported in the article can be found including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. By data we mean the minimal dataset that would be necessary to interpret, replicate and build upon the findings reported in the article. We recognise it is not always possible to share research data publicly, for instance when individual privacy could be compromised, and in such instances data availability should still be stated in the manuscript along with any conditions for access.

    Data availability statements can take one of the following forms (or a combination of more than one if required for multiple datasets):

  • The datasets generated and/or analysed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS]
  • The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
  • All data generated or analysed during this study are included in this published article [and its supplementary information files].
  • The datasets generated and/or analysed during the current study are not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.
  • Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.
  • The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of [third party name].
  • Not applicable. If your manuscript does not contain any data, please state 'Not applicable' in this section.

Data citations should include a persistent identifier (such as a DOI) and should ideally be included in the reference list. Citations of datasets, when they appear in the reference list, should include the minimum information recommended by DataCite and follow journal style. Dataset identifiers including DOIs should be expressed as full URLs.

Post-publication discussions and corrections

In cases where editors or reviewers raise concerns about the ethical integrity of an article we reserve the right to take one of the following courses of action, as deemed appropriate:.

    Data availability statements can take one of the following forms (or a combination of more than one if required for multiple datasets):

  • Publication of a correction
  • Retraction of published article
  • Refusal of future submission
  • Notification of misconduct sent to an author’s institution and/or ethics committee.

Any changes to the list of authors should be submitted to the editorial office for consideration along with a valid explanation for the change. All authors should be in agreement about any such update. Pre-publication the editors will approve any such changes on a case-by-case basis. Post-publication changes to the list of authors will typically need to be made with a published correction, and will again be considered on a case-by-case basis by the editorial board.


The Office of Research Integrity ( defines plagiarism as the "theft or misappropriation of intellectual property and the substantial unattributed textual copying of another's work". Authors must therefore ensure any paraphrasing and summarising of the work of others is properly attributed and cited.

Self-plagiarism refers to reusing one's own prior work without acknowledgement. This includes recycling text that has been previously published; submitting the same article to different publications; or reporting results of one study in separate publications when one would suffice. Once again, please therefore ensure that any summarising or paraphrasing of the author's own work is cited appropriately.

All papers submitted to Rhinology will be screened for plagiarism by iThenticate's advanced plagiarism detection software.

In line with guidelines from COPE (, if plagiarism is identified or suspected in a Rhinology article, we will contact the corresponding author with our findings. In clear cases of plagiarism of large sections of text, the submission will be rejected and all authors will be informed of this decision. If the case is deemed serious enough, we may also refer this to the author's institution. If the plagiarism is deemed minor (i.e. no misattribution of data) we will work with the author to ensure appropriate attribution and citation and the paper will continue through the review process.

If plagiarism is detected in an article which has already been published, the article will be retracted and a retraction statement will be added to the website.

Complaints and appeals

Any complaints about the handling of your article or appeals against an editorial decision should be addressed to in the first instance.